Abstract
Multiple studies have established the efficacy and safety of contemporary drug eluting stents (DES) compared with bare metal stents (BMS) in patients undergoing percutaneous coronary interventions (PCI). However, patients at high-risk for bleeding continue to receive BMS rather than DES given the
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have